Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution
| Image |  |
|---|---|
| Description | scientific article published in June 2010 |
| Author/s |
author: Lorenzo Falchi |
| Publication date | June 1, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |